Prognostic factors of Guillain-Barré syndrome: a 111-case retrospective review

Yitao Zhang, Yanyin Zhao, Yi Wang, Yitao Zhang, Yanyin Zhao, Yi Wang

Abstract

Background: To identify the predictive factors associated with worse prognosis in the Guillain-Barré syndrome (GBS), which can be helpful to fully evaluate the disease progression and provide proper treatments.

Methods: Clinical data of 111 GBS patients who were diagnosed from 2010 to 2015 were collected and retrospectively analyzed.

Results: Patients with diabetes (P=0.031), high blood pressure at admission (P=0.034), uroschesis (P=0.028), fever (P<0.001), ventilator support (P<0.001) during hospitalization, disorder of consciousness (p=0.007) and absence of preceding respiratory infection(P=0.016) were associated with worse outcome at discharge, while abnormal sensation, ataxia, weakness and decrease of tendon reflex seemed not correlated with the Medical Research Council(MRC) score at discharge. Compared with the subtype of acute inflammatory demyelinating polyneuropathy, prognosis of Miller-Fisher syndrome (p<0.001) and cranial nerve variant (p<0.038) were better, but prognosis of acute motor axonal neuropathy(AMAN) was worse (p<0.032). Laboratory examinations at admission showed that hyperglycemia (P=0.002), high leukocyte count (P=0.010), hyperfibrinogenemia (P=0.001), hyponatremia (P=0.020), hypoalbuminemia (P=0.005), abnormal hepatic (P=0.048) and renal (P=0.009) functions were associated with poorer prognosis at discharge, while albuminocytologic dissociation in cerebrospinal fluid, GM1 and GQ1b antibody showed no correlation with the MRC score at discharge. γ-Globulin and glucocorticoid therapies showed no difference in the MRC score at the discharge.

Conclusions: AMAN, diabetes, high blood pressure, uroschesis, high body temperature, ventilator support, consciousness disorder, absence of upper respiratory tract preceding infection, hyperglycemia, hyponatremia, hypoalbuminemia, high leukocyte count, hyperfibrinogenemia, abnormal hepatic and renal function were demonstrated as poor prognostic factors.

Keywords: Guillain-Barre syndrome; Prognostic factors; outcome.

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

© The Author(s) 2018.

References

    1. van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–482. doi: 10.1038/nrneurol.2014.121.
    1. Wakerley BR, Yuki N. Infectious and noninfectious triggers in Guillain-Barre syndrome. Expert Rev Clin Immunol. 2013;9(7):627–639. doi: 10.1586/1744666X.2013.811119.
    1. Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet. 2005;366(9497):1653–1666. doi: 10.1016/S0140-6736(05)67665-9.
    1. Yuki N, Hartung HP. Guillain-Barre syndrome. N Engl J Med. 2012;366(24):2294–2304. doi: 10.1056/NEJMra1114525.
    1. Yuki N, Hirata K. Preserved tendon reflexes in Campylobacter neuropathy. Ann Neurol. 1998;43(4):546–547. doi: 10.1002/ana.410430424.
    1. Kuwabara S, Nakata M, Sung JY, Mori M, Kato N, Hattori T, et al. Hyperreflexia in axonal Guillain-Barre syndrome subsequent to Campylobacter jejuni enteritis. J Neurol Sci. 2002;199(1-2):89–92. doi: 10.1016/S0022-510X(02)00088-6.
    1. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol. 2008;7(10):939–950. doi: 10.1016/S1474-4422(08)70215-1.
    1. Vucic S, Kiernan MC, Cornblath DR. Guillain-Barre syndrome: an update. J Clin Neurosci. 2009;16(6):733–741. doi: 10.1016/j.jocn.2008.08.033.
    1. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123. doi: 10.1159/000324710.
    1. Hughes RA, Swan AV, Raphaël JC, Annane D, Van KR, van Doorn PA. Immunotherapy for Guillain-Barre syndrome: a systematic review. Brain. 2007;130(9):2245–2257. doi: 10.1093/brain/awm004.
    1. Hughes RA, Swan AV, PAV D. Cochrane Review: Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews. 2004;6(1):CD002063.
    1. van Doorn PA. Diagnosis, treatment and prognosis of Guillain-Barre syndrome (GBS) Presse Med. 2013;42(6 Pt 2):e193–e201. doi: 10.1016/j.lpm.2013.02.328.
    1. Dhar R, Stitt L, Hahn AF. The morbidity and outcome of patients with Guillain-Barré syndrome admitted to the intensive care unit. Journal of the Neurological Sciences. 2008;264(1–2):121–128. doi: 10.1016/j.jns.2007.08.005.
    1. Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barre syndrome: incidence and mortality rates in US hospitals. Neurology. 2008;70(18):1608–1613. doi: 10.1212/01.wnl.0000310983.38724.d4.
    1. Van DBB, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology 2013;80(18):1650.
    1. Van KR, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BCA. clinical prognostic scoring system for Guillain-Barre syndrome. Lancet Neurology. 2007;6(7):589–594. doi: 10.1016/S1474-4422(07)70130-8.
    1. Suárez AA, Pessolano FA, Monteiro SG, Ferreyra G, Capria ME, Mesa L, et al. Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease. Am J Phys Med Rehabil. 2002;81(7):506–511. doi: 10.1097/00002060-200207000-00007.
    1. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, et al. Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol. 1998;44(5):780–788. doi: 10.1002/ana.410440512.
    1. Ma YM, Liu TK, Wong V. Guillain-Barre syndrome in southern Chinese children: 32 year experience in Hong Kong. Pediatrics International Official Journal of the Japan Pediatric Society. 2010;52(1):13. doi: 10.1111/j.1442-200X.2009.02951.x.
    1. Ng YS, Lo YL, Lim PA. Characteristics and acute rehabilitation of Guillain-Barre syndrome in Singapore. Ann Acad Med Singap. 2004;33(3):314.
    1. Doorn PAV, Kuitwaard K, Walgaard C, Koningsveld RV, Ruts L, Jacobs BC. DOI 10.1007/s10875-010-9407-4 IVIG Treatment and Prognosis in Guillain–Barré Syndrome. 2010.
    1. Vucic S. Cairns KDBlack KR, Tick Chong PS, Cros D. Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy. Clinical Neurophysiology. 2004;115(10):2329–2335. doi: 10.1016/j.clinph.2004.05.009.
    1. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al.. Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118 ( Pt 3)(3):597.
    1. Mitsui Y, Kusunoki S, Arimura K, Kaji R, Kanda T, Kuwabara S, et al. A multicentre prospective study of Guillain-Barre syndrome in Japan: a focus on the incidence of subtypes. J Neurol Neurosurg Psychiatry. 2015;86(1):110–114. doi: 10.1136/jnnp-2013-306509.
    1. Zhang G, Li Q, Zhang R, Wei X, Wang J, Subtypes QX. Prognosis of Guillain-Barré Syndrome in Southwest China. Plos One. 2015;10(7):e0133520. doi: 10.1371/journal.pone.0133520.
    1. Gonzalez-Suarez I, Sanz-Gallego I, Rodriguez DRF, Arpa J. Guillain-Barre syndrome: natural history and prognostic factors: a retrospective review of 106 cases. BMC Neurol. 2013;13:95. doi: 10.1186/1471-2377-13-95.
    1. Telleria-Diaz A, Calzada-Sierra DJ. Guillain Barre syndrome. Rev Neurol. 2002;34(10):966–976.
    1. Aladro-Benito Y, Conde-Sendin MA, Munoz-Fernandez C, Perez-Correa S, Alemany-Rodriguez MJ, Fiuza-Perez MD, et al. Guillain-Barre syndrome in the northern area of Gran Canaria and the island of Lanzarote. Rev Neurol. 2002;35(8):705–710.
    1. A prospective study on the incidence and prognosis of Guillain-Barre syndrome in Emilia-Romagna region, Italy (1992-1993) Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology. Neurology. 1997;48(1):214–221. doi: 10.1212/WNL.48.1.214.
    1. Lyu RK, Tang LM, Cheng SY, Hsu WC, Chen ST. Guillain-Barre syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry. 1997;63(4):494–500. doi: 10.1136/jnnp.63.4.494.
    1. Cuadrado JI, de Pedro-Cuesta J, Ara JR, Cemillan CA, Diaz M, Duarte J, et al. Guillain-Barre syndrome in Spain, 1985-1997: epidemiological and public health views. Eur Neurol. 2001;46(2):83–91. doi: 10.1159/000050769.
    1. Kuwabara S. Does Campylobacter jejuni infection elicit axonal or demyelinating Guillain-Barre syndrome, or both? J Neurol Neurosurg Psychiatry. 2011;82(3):238. doi: 10.1136/jnnp.2010.237040.
    1. Bae JS, Kim YJ, Kim JK. Diabetes mellitus exacerbates the clinical and electrophysiological features of Guillain-Barre syndrome. Eur J Neurol. 2016;23(3):439–446. doi: 10.1111/ene.12885.
    1. Hartge MM, Unger T, Kintscher U. The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res. 2007;4(2):84–88. doi: 10.3132/dvdr.2007.025.
    1. Bae JS, Kim OK, Kim JM. Altered nerve excitability in subclinical/early diabetic neuropathy: evidence for early neurovascular process in diabetes mellitus? Diabetes Res Clin Pract. 2011;91(2):183–189. doi: 10.1016/j.diabres.2010.11.008.
    1. Naphade PU, Verma R, Garg RK, Singh M, Malhotra HS, Shankwar SN. Prevalence of bladder dysfunction, urodynamic findings, and their correlation with outcome in Guillain-Barre syndrome. Neurourol Urodyn. 2012;31(7):1135–1140. doi: 10.1002/nau.22236.
    1. Watson L, Aziz M, Vassallo G, Plant ND, Webb NJ. Bladder dysfunction and hypertension in children with Guillain-Barre syndrome. Pediatr Nephrol. 2014;29(9):1637–1641. doi: 10.1007/s00467-014-2799-2.
    1. Sakakibara R, Uchiyama T, Kuwabara S, Mori M, Ito T, Yamamoto T, et al. Prevalence and mechanism of bladder dysfunction in Guillain-Barre Syndrome. Neurourol Urodyn. 2009;28(5):432–437. doi: 10.1002/nau.20663.
    1. Kalita J, Misra UK, Goyal G, Das M. Guillain-Barre syndrome: subtypes and predictors of outcome from India. J Peripher Nerv Syst. 2014;19(1):36–43. doi: 10.1111/jns5.12050.
    1. Samukawa M, Hamada Y, Kuwahara M, Takada K, Hirano M, Mitsui Y, et al. Clinical features in Guillain-Barre syndrome with anti-Gal-C antibody. J Neurol Sci. 2014;337(1-2):55–60. doi: 10.1016/j.jns.2013.11.016.
    1. Zochodne DW. Autonomic involvement in Guillain-Barre syndrome: a review. Muscle Nerve. 1994;17(10):1145–1155. doi: 10.1002/mus.880171004.
    1. Nguyen TN, Badjatia N, Malhotra A, Gibbons FK, Qureshi MM, Greenberg SA. Factors predicting extubation success in patients with Guillain-Barre syndrome. Neurocrit Care. 2006;5(3):230–234. doi: 10.1385/NCC:5:3:230.
    1. Lawn ND, Wijdicks EF. Tracheostomy in Guillain-Barre syndrome. Muscle Nerve. 1999;22(8):1058–1062. doi: 10.1002/(SICI)1097-4598(199908)22:8<1058::AID-MUS8>;2-G.
    1. CLARKE E, BAYLISS RI, COOPER R. Landry-Guillain-Barre syndrome: cardiovascular complications; treatment with A.C.T.H. and cortisone. Br Med J. 1954;2(4903):1504–1507. doi: 10.1136/bmj.2.4903.1504.
    1. Samadi M, Kazemi B, Golzari OS, Barzegar M. Assessment of autonomic dysfunction in childhood guillain-barre syndrome. J Cardiovasc Thorac Res. 2013;5(3):81–85.
    1. Hahn AF. The challenge of respiratory dysfunction in Guillain-Barre syndrome. Arch Neurol. 2001;58(6):871–872. doi: 10.1001/archneur.58.6.871.
    1. Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain-Barre syndrome. Arch Neurol. 2001;58(6):893–898. doi: 10.1001/archneur.58.6.893.
    1. Sharshar T, Chevret S, Bourdain F, Raphael JC. Early predictors of mechanical ventilation in Guillain-Barre syndrome. Crit Care Med. 2003;31(1):278–283. doi: 10.1097/00003246-200301000-00044.
    1. Wu X, Li C, Zhang B, Shen D, Li T. Liu K, et al.. Predictors for mechanical ventilation and short-term prognosis in patients with Guillain-Barre syndrome. Crit Care. 2015;19:310. doi: 10.1186/s13054-015-1037-z.
    1. Durand MC, Porcher R, Orlikowski D, Aboab J, Devaux C, Clair B, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barre syndrome: a prospective study. Lancet Neurol. 2006;5(12):1021–1028. doi: 10.1016/S1474-4422(06)70603-2.
    1. Wang Y, Liu J. Hyponatremia is a predictor for poor outcome in Guillain-Barre syndrome. Neurol Res. 2015;37(4):347–351. doi: 10.1179/1743132814Y.0000000455.
    1. Colls BM. Guillain-Barre syndrome and hyponatraemia. Intern Med J. 2003;33(1-2):5–9. doi: 10.1046/j.1445-5994.2002.00322.x.
    1. Saifudheen K, Jose J, Gafoor VA, Musthafa M. Guillain-Barre syndrome and SIADH. Neurology. 2011;76(8):701–704. doi: 10.1212/WNL.0b013e31820d8b40.
    1. Ng KK, Howard RS, Fish DR, Hirsch NP, Wiles CM, Murray NM, et al. Management and outcome of severe Guillain-Barre syndrome. QJM. 1995;88(4):243–250.
    1. Lenhard T, Grimm C, Ringleb PA. Renal salt wasting as part of dysautonomia in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2011;82(9):1051–1053. doi: 10.1136/jnnp.2009.192369.
    1. Oomes PG, van der Meche FG, Kleyweg RP. Liver function disturbances in Guillain-Barre syndrome: a prospective longitudinal study in 100 patients. Dutch Guillain-Barre Study Group. Neurology. 1996;46(1):96–100. doi: 10.1212/WNL.46.1.96.
    1. Khajehdehi P, Shariat A, Nikseresht A. Acute renal failure due to severe Landry-Guillain-Barre syndrome. Nephrol Dial Transplant. 1998;13(9):2388–2391. doi: 10.1093/ndt/13.9.2388.
    1. Buysen JG, Houthoff HJ, Krediet RT, Arisz L. Acute interstitial nephritis: a clinical and morphological study in 27 patients. Nephrol Dial Transplant. 1990;5(2):94–99. doi: 10.1093/ndt/5.2.94.
    1. Suarez AA, Pessolano FA, Monteiro SG, Ferreyra G, Capria ME, Mesa L, et al. Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease. Am J Phys Med Rehabil. 2002;81(7):506–511. doi: 10.1097/00002060-200207000-00007.
    1. Kaida K, Kusunoki S, Kanzaki M, Kamakura K, Motoyoshi K, Kanazawa I. Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barre syndrome. Neurology. 2004;62(5):821–824. doi: 10.1212/01.WNL.0000113718.27729.43.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться